about
Hygiene and emollient interventions for maintaining skin integrity in older people in hospital and residential care settingsTopical treatments for chronic plaque psoriasisTopical treatments for chronic plaque psoriasisRandomized, controlled trial evaluating a baby wash product on skin barrier function in healthy, term neonatesPimecrolimus in atopic dermatitis: consensus on safety and the need to allow use in infantsGenetic analysis of the interleukin-1 receptor antagonist and its homologue IL-1L1 in alopecia areata: strong severity association and possible gene interactionA genome-wide association study identifies new psoriasis susceptibility loci and an interaction between HLA-C and ERAP1.Identification of 15 new psoriasis susceptibility loci highlights the role of innate immunity.Improved emollient use reduces atopic eczema symptoms and is cost neutral in infants: before-and-after evaluation of a multifaceted educational support programme.Computational design of treatment strategies for proactive therapy on atopic dermatitis using optimal control theory.Infant skin-cleansing product versus water: a pilot randomized, assessor-blinded controlled trial.Effectiveness and cost-effectiveness of daily all-over-body application of emollient during the first year of life for preventing atopic eczema in high-risk children (The BEEP trial): protocol for a randomised controlled trial.Emollient enhancement of the skin barrier from birth offers effective atopic dermatitis preventionEffect on skin hydration of using baby wipes to clean the napkin area of newborn babies: assessor-blinded randomised controlled equivalence trialEffect of olive and sunflower seed oil on the adult skin barrier: implications for neonatal skin care.Phytophotodermatitis mimicking child abuse.Adverse effects of topical glucocorticosteroids.Topical preparations for the treatment of psoriasis: a systematic review.Eumovate (clobetasone butyrate 0.05%) cream: a review of clinical efficacy and safety.Genome-wide studies of psoriasis susceptibility loci: a review.New perspectives on epidermal barrier dysfunction in atopic dermatitis: gene-environment interactions.An update on the safety and tolerability of pimecrolimus cream 1%: evidence from clinical trials and post-marketing surveillance.Epidermal barrier dysfunction in atopic dermatitis.Skin barrier breakdown: a renaissance in emollient therapy.Use of emollients in dry-skin conditions: consensus statement.Topical treatments for chronic plaque psoriasis of the scalp: a systematic review.Topical treatments for chronic plaque psoriasis: an abridged Cochrane systematic review.Single nucleotide polymorphisms in the human interleukin-1B gene affect transcription according to haplotype context.Comparison of the Simple Patient-Centric Atopic Dermatitis Scoring System PEST with SCORAD in Young Children Using a Ceramide Dominant Therapeutic Moisturizer.When does atopic dermatitis warrant systemic therapy? Recommendations from an expert panel of the International Eczema Council.A functional mechanistic study of the effect of emollients on the structure and function of the skin barrier.Vitamin D and antimicrobial peptide levels in patients with atopic dermatitis and atopic dermatitis complicated by eczema herpeticum: A pilot study.The Effect of an Emollient Containing Urea, Ceramide NP, and Lactate on Skin Barrier Structure and Function in Older People with Dry Skin.Development of stratum corneum chymotrypsin-like protease activity and natural moisturizing factors from birth to 4 weeks of age compared with adults.Comparing the Effect of a Twice-weekly Tacrolimus and Betamethasone Valerate Dose on the Subclinical Epidermal Barrier Defect in Atopic Dermatitis.Genetic control of cytokines. Cytokine gene polymorphisms in alopecia areata.Erratum to: Comparison of the Simple Patient-Centric Atopic Dermatitis Scoring System PEST with SCORAD in Young Children Using a Ceramide Dominant Therapeutic Moisturizer.Role of the autoimmune regulator (AIRE) gene in alopecia areata: strong association of a potentially functional AIRE polymorphism with alopecia universalis.Severe pruritus in a patient with urticaria pigmentosa treated with topical 5% urea and 3% polidocanol cream.Patient education about topical treatments.
P50
Q24187705-FD650433-3883-4DB4-BAEB-FC456E9DD00BQ24198258-EFF0ECB7-25A5-47EE-97F4-4EE858AECA26Q24241239-8923D77E-A803-47A8-8721-0D618B463AF2Q24619472-B11B446B-BAF4-4680-8067-B5D07C62D8F0Q28086973-0AF69F0C-BA61-4F46-B47B-3F4DD1541CE9Q28200834-4701C249-36C2-4F26-9D95-733514D1FEC6Q29417009-394C6337-5FC4-4F9E-94FE-EB7128F6E5E8Q30419116-FFE8F70F-31D5-4528-B0B4-6BFEFDCC0068Q31117618-9A3B98E7-61D7-4ED9-B2E8-0AFD1D24FF00Q33694845-843040D7-B9D6-41A6-A09D-66CAC7BE1E60Q33899049-C8F158EA-5012-42D7-B2C1-6E1DF78E5A4FQ33922867-E3811F5B-C4BF-48E0-902C-11BF45123006Q34266725-5BB3D6EE-F30D-42A2-BDCD-63E3B2251483Q34289390-55A18F8F-D63B-4DD0-A9AF-63AA84667F38Q34300802-F41E8FCC-161E-45BC-AC1C-97F7B97739D0Q34364079-D844BDC7-81BF-405C-8177-C5FC77DC1BACQ34480503-2CDF9989-8DBC-43C6-AC5B-2FADCFF50271Q34600456-87879D07-BBCE-4C7F-B5AA-4799F5B104B3Q35140372-3A762D13-114B-466F-8CA6-F33325F6B71CQ35894157-F6DB234F-A710-4DB2-AF97-168ACD8483F8Q36525095-D1C75409-4605-414E-9D91-3CA222DD60BBQ37049990-445F9E23-9BCD-49BB-86D6-64AE7B4B7378Q37507508-B4AE9497-0EA7-4952-86B0-773BF05733C2Q37562860-2EEF5C06-B9AE-4577-A909-592BEB6286F8Q38091734-6743F63C-348E-40E9-82BE-2185C91D492BQ38116596-1A2D4D17-3F77-40DC-94AB-DC9474D41740Q38152471-52187188-E99D-4648-8654-164B271BF4B2Q38316988-B721F08D-4644-43C0-9652-448C3F48EE5BQ38375544-6839360E-EF13-4D09-81F7-29ACA025D936Q40095599-AF3C317E-1093-46B0-9C5C-BFF12A5E0690Q40481331-8A792CF2-FCA0-4B9C-B94D-C965DA2508B6Q40576528-8F20DD7A-ECBD-4DEE-B2CF-95769D1F68B5Q40649516-7F831629-A68C-4601-8475-70D0952D0E92Q40749056-FD0C33F0-E201-470C-9736-CDD5E90ACD39Q41541016-3F7C50BF-3EA6-451A-B0A1-AD563C1E5808Q41545413-CEFAB5A8-B753-47D2-9C89-F1C2AC24E227Q42351115-B515FF0E-4639-4A7E-BCD6-632E997B4345Q44287914-F392F874-FAEB-4030-AB75-E06444432C6EQ44604991-B6FF000B-8B07-4004-98AA-8CFA6976B0EDQ44939341-8AA4A882-9711-4866-9591-1080917E3EA1
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Michael J. Cork
@ast
Michael J. Cork
@en
Michael J. Cork
@es
Michael J. Cork
@nl
Michael J. Cork
@sl
type
label
Michael J. Cork
@ast
Michael J. Cork
@en
Michael J. Cork
@es
Michael J. Cork
@nl
Michael J. Cork
@sl
altLabel
Cork M
@en
Cork MJ
@en
M Cork
@en
MJ Cork
@en
Michael J. Cork
@en
Michael John Cork
@en
Mike Cork
@en
prefLabel
Michael J. Cork
@ast
Michael J. Cork
@en
Michael J. Cork
@es
Michael J. Cork
@nl
Michael J. Cork
@sl
P106
P1153
7003568973
P2031
1991-01-01T00:00:00Z
P21
P31
P496
0000-0003-4428-2428